Protara Therapeutics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
345 Park Ave S Fl 3, New York, New York,...Phone Number
(646) 844-0337Website
www.protaratx.comRevenue
$10.1 MillionStock Symbol
TARAIndustry
About Protara Therapeutics
Protara is focused on identifying and optimizing product candidates for patients suffering from rare and specialty diseases where there is a significant unmet need. Protara's current development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. The Company's lead program, TARA-002, is being developed for the treatment of lymphatic malformations. Protara's second program, IV choline chloride, is a phospholipid substrate replacement therapy in development for the treatment of intestinal failure-associated liver disease.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: TARAShow moreProtara Therapeutics Org Chart
Compare Similar Companies to Protara Therapeutics
Compare insights from companies similar to Protara Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Protara Therapeutics Tech Stack
A closer look at the technologies used by Protara Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Protara Therapeutics
Sign Up For FreeTo access detailed company insights
Protara is focused on identifying and optimizing product candidates for patients suffering from rare and specialty diseases where there is a significant unmet need. Protara's current development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.... Read More
